Main Session
Sep
27
SS 02 - Escalate, De-escalate, or Substitute? Trials Shaping Prostate Cancer Care
109 - <em>I</em>ntermittent Androgen Deprivation Therapy with or without <em>St</em>ereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive <em>O</em>ligometastatic <em>P</em>rostate Cancer: A Randomized Study (i-STOP)
Presenter(s)
Patrick Cheung, MD - Sunnybrook Odette Cancer Centre, Toronto, Ontario